198 related articles for article (PubMed ID: 19035445)
21. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
[TBL] [Abstract][Full Text] [Related]
23. Associations between serum carotenoid levels and the risk of non-Hodgkin lymphoma: a case-control study.
Li S; Zhu X; Zhu L; Hu X; Wen S
Br J Nutr; 2020 Dec; 124(12):1311-1319. PubMed ID: 32349798
[TBL] [Abstract][Full Text] [Related]
24. Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer.
Mondul AM; Weinstein SJ; Virtamo J; Albanes D
Br J Cancer; 2012 Oct; 107(9):1589-94. PubMed ID: 22990651
[TBL] [Abstract][Full Text] [Related]
25. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
26. Dietary factors of one-carbon metabolism in relation to non-Hodgkin lymphoma and multiple myeloma in a cohort of male smokers.
Lim U; Weinstein S; Albanes D; Pietinen P; Teerenhovi L; Taylor PR; Virtamo J; Stolzenberg-Solomon R
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1109-14. PubMed ID: 16775167
[TBL] [Abstract][Full Text] [Related]
27. Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.
Lai GY; Wang JB; Weinstein SJ; Parisi D; Horst RL; McGlynn KA; Männistö S; Albanes D; Freedman ND
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1075-1082. PubMed ID: 29720370
[No Abstract] [Full Text] [Related]
28. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
[TBL] [Abstract][Full Text] [Related]
29. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
[TBL] [Abstract][Full Text] [Related]
30. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study.
Chang ET; Canchola AJ; Cockburn M; Lu Y; Wang SS; Bernstein L; Clarke CA; Horn-Ross PL
Blood; 2011 Aug; 118(6):1591-9. PubMed ID: 21622649
[TBL] [Abstract][Full Text] [Related]
31. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.
Albanes D; Mondul AM; Yu K; Parisi D; Horst RL; Virtamo J; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1850-60. PubMed ID: 21784952
[TBL] [Abstract][Full Text] [Related]
32. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
[TBL] [Abstract][Full Text] [Related]
33. Pre-diagnostic circulating vitamin D and risk of melanoma in men.
Major JM; Kiruthu C; Weinstein SJ; Horst RL; Snyder K; Virtamo J; Albanes D
PLoS One; 2012; 7(4):e35112. PubMed ID: 22558121
[TBL] [Abstract][Full Text] [Related]
34. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
Nieters A; Łuczyńska A; Becker S; Becker N; Vermeulen R; Overvad K; Aleksandrova K; Boeing H; Lagiou P; Trichopoulos D; Trichopoulou A; Krogh V; Masala G; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Jeurnink SM; Weiderpass E; Ardanaz E; Chirlaque MD; Sánchez MJ; Sánchez S; Borgquist S; Butt S; Melin B; Späth F; Rinaldi S; Brennan P; Kelly RS; Riboli E; Vineis P; Kaaks R
Carcinogenesis; 2014 Dec; 35(12):2716-22. PubMed ID: 25269801
[TBL] [Abstract][Full Text] [Related]
35. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.
Weinstein SJ; Mondul AM; Yu K; Layne TM; Abnet CC; Freedman ND; Stolzenberg-Solomon RZ; Lim U; Gail MH; Albanes D
Eur J Epidemiol; 2018 Nov; 33(11):1087-1099. PubMed ID: 30073448
[TBL] [Abstract][Full Text] [Related]
36. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
[TBL] [Abstract][Full Text] [Related]
37. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
[TBL] [Abstract][Full Text] [Related]
38. Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Travis RC; Crowe FL; Allen NE; Appleby PN; Roddam AW; Tjønneland A; Olsen A; Linseisen J; Kaaks R; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Vineis P; Palli D; Tumino R; Sieri S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Chirlaque MD; Barricarte A; Larrañaga N; González CA; Argüelles MV; Sánchez MJ; Stattin P; Hallmans G; Khaw KT; Bingham S; Rinaldi S; Slimani N; Jenab M; Riboli E; Key TJ
Am J Epidemiol; 2009 May; 169(10):1223-32. PubMed ID: 19359375
[TBL] [Abstract][Full Text] [Related]
39. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Gallicchio L; Helzlsouer KJ; Chow WH; Freedman DM; Hankinson SE; Hartge P; Hartmuller V; Harvey C; Hayes RB; Horst RL; Koenig KL; Kolonel LN; Laden F; McCullough ML; Parisi D; Purdue MP; Shu XO; Snyder K; Stolzenberg-Solomon RZ; Tworoger SS; Varanasi A; Virtamo J; Wilkens LR; Xiang YB; Yu K; Zeleniuch-Jacquotte A; Zheng W; Abnet CC; Albanes D; Bertrand K; Weinstein SJ
Am J Epidemiol; 2010 Jul; 172(1):10-20. PubMed ID: 20562188
[TBL] [Abstract][Full Text] [Related]
40. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]